Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 21677024)

1.

Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.

Rossi S, Mancino R, Bergami A, Mori F, Castelli M, De Chiara V, Studer V, Mataluni G, Sancesario G, Parisi V, Kusayanagi H, Bernardi G, Nucci C, Bernardini S, Martino G, Furlan R, Centonze D.

Mult Scler. 2011 Nov;17(11):1301-12. doi: 10.1177/1352458511410342. Epub 2011 Jun 15.

PMID:
21677024
2.

Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.

Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, Musella A, Bergami A, Muzio L, Bernardi G, Battistini L, Martino G, Centonze D.

Ann Neurol. 2012 Jan;71(1):76-83. doi: 10.1002/ana.22512.

PMID:
22275254
3.

Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.

Caramia MD, Palmieri MG, Desiato MT, Boffa L, Galizia P, Rossini PM, Centonze D, Bernardi G.

Clin Neurophysiol. 2004 Apr;115(4):956-65.

PMID:
15003779
4.

Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.

Conte A, Lenzi D, Frasca V, Gilio F, Giacomelli E, Gabriele M, Bettolo CM, Iacovelli E, Pantano P, Pozzilli C, Inghilleri M.

J Neurol. 2009 Jun;256(6):933-8. doi: 10.1007/s00415-009-5047-0. Epub 2009 Mar 1.

PMID:
19252788
5.

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

Fainardi E, Rizzo R, Melchiorri L, Vaghi L, Castellazzi M, Marzola A, Govoni V, Paolino E, Tola MR, Granieri E, Baricordi OR.

J Neuroimmunol. 2003 Sep;142(1-2):149-58.

PMID:
14512174
6.

Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis.

Bock M, Brandt AU, Kuchenbecker J, Dörr J, Pfueller CF, Weinges-Evers N, Gaede G, Zimmermann H, Bellmann-Strobl J, Ohlraun S, Zipp F, Paul F.

Br J Ophthalmol. 2012 Jan;96(1):62-7. doi: 10.1136/bjo.2010.193581. Epub 2011 Mar 3.

PMID:
21378002
7.

Cortical dysfunction underlies disability in multiple sclerosis.

Vucic S, Burke T, Lenton K, Ramanathan S, Gomes L, Yannikas C, Kiernan MC.

Mult Scler. 2012 Apr;18(4):425-32. doi: 10.1177/1352458511424308. Epub 2011 Sep 30.

PMID:
21965421
8.

Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.

Zaveri MS, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM.

Arch Neurol. 2008 Jul;65(7):924-8. doi: 10.1001/archneur.65.7.924.

PMID:
18625859
9.

Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis.

Mori F, Nicoletti CG, Rossi S, Motta C, Kusayanagi H, Bergami A, Studer V, Buttari F, Barbieri F, Weiss S, Nisticò R, Martino G, Furlan R, Centonze D.

Neuromolecular Med. 2014 Jun;16(2):490-8. doi: 10.1007/s12017-014-8297-7. Epub 2014 Mar 27.

PMID:
24671722
10.
11.

Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.

Mori F, Rossi S, Sancesario G, Codecà C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D.

Neuropsychopharmacology. 2011 Feb;36(3):559-68. doi: 10.1038/npp.2010.187. Epub 2010 Oct 13.

12.

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.

Teunissen CE, Koel-Simmelink MJ, Pham TV, Knol JC, Khalil M, Trentini A, Killestein J, Nielsen J, Vrenken H, Popescu V, Dijkstra CD, Jimenez CR.

Mult Scler. 2011 Jul;17(7):838-50. doi: 10.1177/1352458511399614. Epub 2011 Apr 19.

PMID:
21505015
13.

Gray matter atrophy is related to long-term disability in multiple sclerosis.

Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.

Ann Neurol. 2008 Sep;64(3):247-54. doi: 10.1002/ana.21423. Erratum in: Ann Neurol. 2009 Feb;65(2):232.

PMID:
18570297
14.

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.

Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N.

Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15.

PMID:
23069872
15.

Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.

Alexander JS, Harris MK, Wells SR, Mills G, Chalamidas K, Ganta VC, McGee J, Jennings MH, Gonzalez-Toledo E, Minagar A.

Mult Scler. 2010 Jul;16(7):801-9. doi: 10.1177/1352458510370791.

PMID:
20621951
16.

Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.

Correale J, Fiol M.

Mult Scler. 2011 May;17(5):521-31. doi: 10.1177/1352458510392619. Epub 2010 Dec 15.

PMID:
21159721
17.

Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study.

Liepert J, Mingers D, Heesen C, Bäumer T, Weiller C.

Mult Scler. 2005 Jun;11(3):316-21.

PMID:
15957514
18.

Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis.

Guimarães I, Cardoso MI, Sá MJ.

Mult Scler. 2006 Jun;12(3):354-6.

PMID:
16764350
19.

Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging.

Cid C, Alcázar A, Regidor I, Masjuan J, Salinas M, Alvarez-Cermeño JC.

J Neurol Sci. 2002 Jan 15;193(2):103-9.

PMID:
11790390
20.

Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis.

Rossi S, Studer V, Motta C, Germani G, Macchiarulo G, Buttari F, Mancino R, Castelli M, De Chiara V, Weiss S, Martino G, Furlan R, Centonze D.

J Neuroinflammation. 2014 Feb 18;11:32. doi: 10.1186/1742-2094-11-32.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk